Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.78 |
| ▸ | PGD | P52209 | 3/20 | 0.50 |
| ▸ | PGK1 | P00558 | 1/20 | 0.44 |
| ▸ | PGK2 | P07205 | 1/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.36 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9741443 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL939515 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL9738232 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL9736731 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL21609 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL321875 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL9737704 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| Ammonia Solution, Strong SCHEMBL638028 | 0.98 | MPI (0.75) | MPIPGDPGK1PGK2S1PR4 | |
| Water SCHEMBL22390105 | 0.98 | MPI (0.75) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL10435219 | 0.98 | MPI (0.75) | MPIPGDPGK1PGK2S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10123953-B2 | Reduction of tooth staining derived from cationic antimicrobials | THE PROCTER & GAMBLE COMPANY (US) | 2018-11-13 | — | — | US | claimed |
| EP-2863863-B1 | REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIMICROBIALS | PROCTER & GAMBLE (US) | 2018-05-30 | — | — | EP | claimed |
| CN-103710318-B | Method for producing stevioside compounds by using microorganisms | 中国科学院上海生命科学研究院 | 2017-01-18 | — | — | CN | claimed |
| EP-2863863-A1 | REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIMICROBIALS | The Procter & Gamble Company (US) | 2015-04-29 | — | — | EP | claimed |
| WO-2013192463-A1 | REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIMICROBIALS | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-27 | — | — | WO | claimed |
| US-20130344011-A1 | Reduction Of Tooth Staining Derived From Cationic Antimicrobials | THE PROCTER & GAMBLE COMPANY | 2013-12-26 | — | — | US | claimed |
| JP-6277083-A | — | — | None | — | — | JP | disclosed |
| WO-2026102217-A2 | INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-12595488-B2 | Insecticidal proteins from plants and methods for their use | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| EP-4674268-A2 | INSECTICIDAL PROTEINS FROM PLANTS AND METHODS FOR THEIR USE | Pioneer Hi-Bred International, Inc. (US) | 2026-01-07 | — | — | EP | disclosed |
| EP-3764798-B1 | INSECTICIDAL PROTEINS FROM PLANTS AND METHODS FOR THEIR USE | PIONEER HI BRED INT (US) | 2025-12-17 | — | — | EP | disclosed |
| EP-4659582-A2 | INSECTICIDAL PROTEINS FROM PLANTS AND METHODS FOR THEIR USE | Pioneer Hi-Bred International, Inc. (US) | 2025-12-10 | — | — | EP | disclosed |
| EP-3764796-B1 | INSECTICIDAL PROTEINS FROM PLANTS AND METHODS FOR THEIR USE | PIONEER HI BRED INT (US) | 2025-12-03 | — | — | EP | disclosed |
| EP-0460709-A1 | AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques | INTERNATIONAL GENETIC ENGINEERING, INC. (INGENE) (US) | 1991-12-11 | — | — | EP | disclosed |
| EP-0514588-A2 | Novel phosphobetaine and detergent and cosmetic containing the same | Kao Corporation (JP) | 1991-11-25 | — | — | EP | disclosed |
| WO-1991009604-A1 | A PHARMACEUTICAL COMPOSITION COMPRISING A PHOSPHOSUGAR | PERSTORP AB (SE) | 1991-07-11 | — | — | WO | disclosed |
| US-5028530-A | Controlling gene expression in bacteria | XOMA CORPORATION (US) | 1991-07-02 | — | — | US | disclosed |
| EP-0211047-A4 | ARAB PROMOTERS AND METHOD OF PRODUCING POLYPEPTIDES, INCLUDINN CECROPINS, BY MICROBIOLOGICAL TECHNIQUES. | INTERNAT GENETIC ENGINEERING I (US) | 1989-04-24 | — | — | EP | disclosed |
| EP-0211047-A1 | ARAB PROMOTERS AND METHOD OF PRODUCING POLYPEPTIDES, INCLUDINN CECROPINS, BY MICROBIOLOGICAL TECHNIQUES. | INT GENETIC ENG (US) | 1987-02-25 | — | — | EP | disclosed |
| WO-1986004356-A1 | AraB PROMOTERS AND METHOD OF PRODUCING POLYPEPTIDES, INCLUDINN CECROPINS, BY MICROBIOLOGICAL TECHNIQUES | INTERNATIONAL GENETIC ENGINEERING, INC. (US) | 1986-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10123953-B2 | Reduction of tooth staining derived from cationic antimicrobials | SOD1, ZRANB2, SLC30A5 | MPI 2433/4885PGD 967/4885PGK1 3016/4885 |
| US-12595488-B2 | Insecticidal proteins from plants and methods for their use | RNGTT, FBL, PHAX | MPI 979/4885PGD 2474/4885PGK1 3331/4885 |
| US-20130344011-A1 | Reduction Of Tooth Staining Derived From Cationic Antimicrobials | SOD1, ZRANB2, SLC30A5 | MPI 2433/4885PGD 967/4885PGK1 3016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.